Published in Gene Therapy Weekly, December 22nd, 1997
A major obstacle for many gene therapy protocols is making sure that every cell slotted for transduction is actually transduced with the therapeutic gene before being introduced into the patient. Failure to do this can result in decreased therapeutic efficacy and/or the introduction of therapy resistant cells into the patient.
Aiming for 100 percent selection of transduced cells, B. Garcia-Hernandez and colleagues from the Instituto de Microbiologia Bioquimica and the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.